Form D · Other Technology
Xpecting Diagnostics Inc.
Omaha, NE · CIK 0001657310
Offering snapshot reported Nov 10, 2015 · SEC filing
- Reported sold
- $57K Offering amount: $550K
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 28, 2015 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 10, 2015 | Initial | $57,000 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-250971
Seed preferred and underlying common shares
Source: Form D, filed Nov 10, 2015. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| James Bogenberger | Director |
| Douglas Chenin | Director |
| Tanner Hagelstrom | Director, Executive |
Issuer details
Industry: Other Technology (See others in industry)
Address:
15918 Harney Street
Omaha, NE, 68118
Omaha, NE, 68118